Quinn Anthony
Insider CIK 1532219 · AGLE interim Chief Medical Officer, Director · GBIO Director · KLDO Director · GEVA SVP, Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 6,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 3,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 5,200 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 1,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 1,920 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 2,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 7,283 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 29,928 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2025-06-04 | 2025-06-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2025-01-13 | 2025-01-14 | 85,000 | $0.97 | $82.5K | 299,286 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2025-01-10 | 2025-01-14 | 125,791 | $0.96 | $120.8K | 214,286 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2024-06-06 | 2024-06-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2023-12-01 | 2023-12-05 | 88,495 | $1.41 | $124.8K | 88,495 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2022-06-09 | 2022-06-13 | 19,200 | — | $0 | 19,200 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2022-03-16 | 2022-03-18 | 80,079 | $2.34 | $187.4K | 550,540 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2022-03-15 | 2022-03-15 | 42,417 | $1.86 | $78.9K | 473,461 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2022-03-14 | 2022-03-15 | 67,472 | $1.93 | $130.2K | 431,044 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2022-03-11 | 2022-03-15 | 34,777 | $2.06 | $71.6K | 363,572 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2022-02-17 | 2022-02-22 | 350,000 | — | $0 | 350,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2021-12-10 | 2021-12-13 | 10,526 | $3.75 | $39.5K | 328,795 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2021-12-09 | 2021-12-13 | 43,108 | $3.70 | $159.5K | 318,269 | SEC↗ |
| GBIO Generation Bio Co. | G Gift | 2021-10-28 | 2021-10-29 | 72,837 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | G Gift | 2021-10-28 | 2021-10-29 | 72,837 | — | $0 | 72,837 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2021-06-30 | 2021-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2021-02-17 | 2021-02-19 | 330,000 | — | $0 | 330,000 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2020-06-30 | 2020-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 53,654 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-18 | 30,376 | — | $0 | 72,837 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2020-06-11 | 2020-06-15 | 52,000 | — | $0 | 52,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2020-04-30 | 2020-05-04 | 165,000 | $4.75 | $783.8K | 538,469 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2020-02-14 | 2020-02-19 | 301,000 | — | $0 | 301,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2019-10-04 | 2019-10-07 | 17,603 | — | $0 | 119,914 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2019-10-04 | 2019-10-07 | 662 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2019-10-04 | 2019-10-07 | 662 | $5.46 | $3.6K | 354,305 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2019-10-04 | 2019-10-07 | 17,603 | $6.31 | $111.1K | 371,908 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-06-14 | 2019-06-14 | 5,282 | $6.23 | $32.9K | 353,643 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-06-13 | 2019-06-14 | 14,406 | $6.17 | $88.9K | 348,361 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-06-12 | 2019-06-14 | 12,217 | $6.11 | $74.6K | 333,955 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-05-22 | 2019-05-22 | 3,809 | $6.86 | $26.1K | 321,738 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-05-21 | 2019-05-22 | 13,794 | $6.89 | $95.0K | 317,929 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-05-20 | 2019-05-22 | 8,989 | $6.56 | $59.0K | 304,135 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-05-17 | 2019-05-17 | 6,218 | $6.65 | $41.3K | 295,146 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-05-16 | 2019-05-17 | 5,520 | $6.83 | $37.7K | 288,928 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-05-15 | 2019-05-17 | 6,256 | $6.76 | $42.3K | 283,408 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-04 | 25,707 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-04 | 12,853 | — | $0 | 31,603 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2019-02-28 | 2019-03-01 | 280,000 | — | $0 | 280,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2019-02-15 | 2019-05-17 | 719 | $7.10 | $5.1K | 277,152 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2019-02-06 | 2019-02-08 | 1,323 | — | $0 | 662 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2019-02-06 | 2019-02-08 | 7,433 | — | $0 | 137,517 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2019-02-06 | 2019-02-08 | 7,433 | $6.31 | $46.9K | 276,433 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2019-02-06 | 2019-02-08 | 1,323 | $5.46 | $7.2K | 269,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-12-07 | 2018-12-10 | 3,306 | — | $0 | 1,985 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-12-07 | 2018-12-10 | 18,584 | — | $0 | 144,950 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-12-07 | 2018-12-10 | 150,000 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-12-07 | 2018-12-10 | 150,000 | $4.11 | $616.5K | 245,787 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-12-07 | 2018-12-10 | 3,306 | $5.46 | $18.1K | 249,093 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-12-07 | 2018-12-10 | 18,584 | $6.31 | $117.3K | 267,677 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2018-08-15 | 2018-12-10 | 994 | $9.13 | $9.1K | 95,787 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-07-18 | 2018-07-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-07-18 | 2018-07-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-07-18 | 2018-07-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-07-18 | 2018-07-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-07-12 | 2018-07-16 | 24,000 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-07-12 | 2018-07-16 | 14,866 | — | $0 | 163,534 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-07-12 | 2018-07-16 | 24,000 | $7.04 | $169.0K | 77,927 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-07-12 | 2018-07-16 | 14,866 | $6.31 | $93.8K | 92,793 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-07-11 | 2018-07-13 | 3,307 | — | $0 | 5,291 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-07-11 | 2018-07-13 | 3,307 | $5.46 | $18.1K | 53,927 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-02-20 | 2018-02-22 | 178,400 | — | $0 | 178,400 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2018-02-15 | 2018-12-10 | 2,000 | $6.02 | $12.0K | 94,793 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise deriv | 2018-02-15 | 2018-02-20 | 15,211 | — | $0 | 8,598 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | M Exercise | 2018-02-15 | 2018-02-20 | 15,211 | $5.46 | $83.1K | 50,620 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-08 | 2017-12-08 | 600 | $5.07 | $3.0K | 35,409 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-07 | 2017-12-08 | 2,800 | $4.99 | $14.0K | 34,809 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-06 | 2017-12-08 | 4,888 | $4.92 | $24.0K | 32,009 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-05 | 2017-12-05 | 5,065 | $4.93 | $25.0K | 27,121 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-04 | 2017-12-05 | 7,956 | $4.98 | $39.6K | 22,056 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-01 | 2017-12-05 | 4,100 | $4.53 | $18.6K | 14,100 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-08-31 | 2017-09-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-04-21 | 2017-04-25 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2016-04-12 | 2016-04-12 | 10,000 | $10.00 | $100.0K | 10,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 20,497 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 35,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 45,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 45,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 37,228 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 5,982 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 8,964 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 27,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 5,675 | — | $0 | 27,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-22 | 2015-06-23 | 38 | $78.87 | $3.0K | 32,675 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-05 | 2015-06-09 | 27,000 | — | $0 | 32,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-04-27 | 2015-04-29 | 10,000 | — | $0 | 37,228 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-04-27 | 2015-04-29 | 10,000 | $1.70 | $17.0K | 15,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-04-27 | 2015-04-29 | 10,000 | $110.00 | $1.10M | 5,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-04-21 | 2015-04-23 | 10,000 | $108.00 | $1.08M | 5,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-04-15 | 2015-04-17 | 10,000 | — | $0 | 35,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-04-15 | 2015-04-17 | 10,000 | $105.00 | $1.05M | 15,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-04-15 | 2015-04-17 | 10,000 | $40.74 | $407.4K | 25,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-04-06 | 2015-04-08 | 9,503 | — | $0 | 20,497 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-04-06 | 2015-04-08 | 10,000 | — | $0 | 8,964 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-04-06 | 2015-04-08 | 10,000 | $0.95 | $9.5K | 35,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-04-06 | 2015-04-08 | 9,503 | $23.00 | $218.6K | 45,140 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-04-06 | 2015-04-08 | 29,503 | $93.76 | $2.77M | 15,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-04-06 | 2015-04-08 | 42 | $76.88 | $3.2K | 25,637 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-09-02 | 2014-09-04 | 10,000 | — | $0 | 30,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-09-02 | 2014-09-04 | 700 | $71.96 | $50.4K | 25,895 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-09-02 | 2014-09-04 | 400 | $70.50 | $28.2K | 26,595 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-09-02 | 2014-09-04 | 300 | $72.88 | $21.9K | 25,595 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-09-02 | 2014-09-04 | 10,000 | $23.00 | $230.0K | 35,595 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-09-02 | 2014-09-04 | 8,600 | $69.88 | $601.0K | 26,995 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2014-06-30 | 2014-07-02 | 71 | $54.89 | $3.9K | 25,595 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-01 | 2014-04-03 | 10,000 | — | $0 | 28,964 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-01 | 2014-04-03 | 10,000 | — | $0 | 40,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-01 | 2014-04-03 | 10,000 | — | $0 | 18,964 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-04-01 | 2014-04-03 | 3,529 | $83.50 | $294.7K | 21,320 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-01 | 2014-04-03 | 10,000 | $0.95 | $9.5K | 25,524 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-01 | 2014-04-03 | 10,000 | $23.00 | $230.0K | 35,524 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-04-01 | 2014-04-03 | 10,675 | $82.80 | $883.9K | 24,849 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-04-01 | 2014-04-03 | 4,746 | $84.72 | $402.1K | 16,574 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-04-01 | 2014-04-03 | 1,050 | $85.76 | $90.0K | 15,524 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-01 | 2014-04-03 | 10,000 | $0.95 | $9.5K | 25,524 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2013-12-31 | 2014-01-02 | 192 | $36.30 | $7.0K | 15,524 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2013-06-28 | 2013-07-01 | 297 | $35.68 | $10.6K | 15,332 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-01-18 | 2013-01-23 | 9,447 | — | $0 | 38,964 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-01-18 | 2013-01-23 | 9,447 | $50.08 | $473.1K | 15,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-01-18 | 2013-01-23 | 9,447 | $0.95 | $9.0K | 24,482 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-01-17 | 2013-01-18 | 200 | — | $0 | 48,411 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-01-17 | 2013-01-18 | 200 | $0.95 | $190 | 15,235 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-01-17 | 2013-01-18 | 200 | $50.00 | $10.0K | 15,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-01-16 | 2013-01-18 | 353 | — | $0 | 48,611 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-01-16 | 2013-01-18 | 353 | $0.95 | $335 | 20,388 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-01-16 | 2013-01-18 | 5,353 | $50.07 | $268.0K | 15,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-07-27 | 2012-07-30 | 6,400 | — | $0 | 48,964 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-07-27 | 2012-07-30 | 6,400 | $0.95 | $6.1K | 26,435 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-07-27 | 2012-07-30 | 6,400 | $50.23 | $321.5K | 20,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-07-26 | 2012-07-30 | 1,100 | — | $0 | 55,364 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-07-26 | 2012-07-30 | 1,100 | $50.00 | $55.0K | 20,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-07-26 | 2012-07-30 | 1,100 | $0.95 | $1.0K | 21,135 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-07-20 | 2012-07-23 | 600 | — | $0 | 56,464 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-07-20 | 2012-07-23 | 600 | $0.95 | $570 | 20,635 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-07-20 | 2012-07-23 | 600 | $50.00 | $30.0K | 20,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-07-19 | 2012-07-23 | 1,900 | — | $0 | 57,064 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-07-19 | 2012-07-23 | 1,900 | $0.95 | $1.8K | 21,935 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-07-19 | 2012-07-23 | 1,900 | $50.00 | $95.0K | 20,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-06-25 | 2012-06-27 | 26,000 | $40.65 | $1.06M | 20,035 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2011-12-20 | 2012-01-11 | 50,000 | — | $0 | 50,000 | SEC↗ |